General principles

• Every child in NZ <18 years of age is funded for NIS vaccines regardless of immigration status.

• Some NIS vaccines are funded for people eligible for NZ funded healthcare over 18 years of age.

• People immunised overseas are transferred to the current NZ NIS and, if required, an age appropriate catch-up programme is planned.

• Identify documented antigens previously received and at what age (Note: HepB birth doses do not count as part of primary course).

• Do not repeat prior doses or restart a vaccine course, even if significant time has elapsed.

• Plan a catch-up immunisation schedule to protect as soon as possible.

• Ensure a minimum 4-week (28 day) interval between vaccines of same antigen, except 8-week interval between first two doses of PCV and final two doses of HepB should be at least six months apart.

• When giving different live vaccines, give on same day or minimum 4-week (28 day) interval.

• DTaP-IPV-HepB/Hib (Infanrix®-hexa) and DTaPIPV (Infanrix®-IPV) can be used up to 10 years of age.

• For at risk or special groups eg pneumococcal or BCG, refer to Immunisation Handbook.

Quick links

3 months to under 12 months

12 months to under 5 years

5 years to under 18 years

18 years and over

3 months to under 12 months

DTaP-IPV-HepB/Hib + PCV + RV*

   4-week interval

DTaP-IPV-HepB/Hib + RV*

   4-week interval unless under 5 months


   At 4 year event


* RV: 1st dose before 15 weeks, 2nd dose before 25 weeks. 

Minimum antigens to receive by 12 months:

3 DTaP   3 IPV   3 HepB   3 Hib   2 PCV   2RV

12 months to under 5 years

DTaP-IPV-HepB/Hib + PCV** + MMR + VV

   4-week interval

DTaP-IPV-HepB/Hib* + MMR

   4-week interval

DTaP-IPV-HepB/Hib*+ PCV**

   6-month gap or at 4 years whichever is later


* Hib; one dose only required 12 months to under 5 years. There are no safety concerns re any extra doses of Hib or HepB. If parental concern, can use separate DTaP-IPV and HepB or Hib.

* If a 4th dose of tetanus containing vaccine was given overseas under age 3 years, a 4-year dose is still recommended.

** If two doses of PCV given <12 months a booster of PCV is needed after 12 months of age. If one dose of PCV given <12 months or two doses not 8 weeks apart, two doses of PCV are needed 8 weeks apart.

Minimum antigens to receive by 5 years

3 or 4 DTaP  3 or 4 IPV  3 or 4 HepB

2 PCV   2 MMR   1 W    1 Hib

5 years to under 10 years

DTaP-IPV-HepB/Hib* + MMR

   4-week interval

DTaP-IPV-HepB/Hib* + MMR

   4-week interval


   6-month interval


* Hib and PCV vaccinations are not required over age 5 years.

* No safety concerns re extra Hib, Hep B or IPV doses when using DTaP-IPV-HepB/Hib or DTaP-IPV. If parental concern, can use Tdap as an alternative over age of 7 years plus separate HepB and IPV.

Minimum antigens to receive by 10 years

4 DTaP   3 IPV   3 or 4 HepB   2 MMR

10 to <18 years

Tdap + IPV + MMR + HepB*

   4-week interval

Tdap + IPV + MMR + HepB*

   4-week interval

Tdap + IPV

   6-month interval or at 11 years whichever is later

Tdap + HepB* + VV**

* HepB – 3 HepB at 0, 1 and 6 months, or alternative for 11 - 15 year olds – 2 dose HepB at 0 and 6 months.

** Varicella vaccine if eligible

From age 12 years

Include HPV vaccine - number of doses and spacing dependent on age – see notes below.

Antigen Requirements

4 Tdap   3 IPV   2 MMR   1 W   2 or 3 HepB   

Adult >18 years

Tdap + IPV + MMR

   4-week interval

Tdap + IPV + MMR

   4-week interval

Tdap + IPV

3 HPV (eligible if 1st dose given before 27 years standard schedule 0, 2, 6 months)

Antigen requirements

3 Tdap   3 IPV   2 MMR   3 HPV

Refer to notes below



Every pregnancy from 2nd trimester

Adult boosters offered from 45 & 65 years of age


Annually, every pregnancy, aged 65y and over, and those 6 months of age in defined risk groups

(see more on influenza.org.nz)


Two documented doses over 12 months of age, with minimum 4-week interval required, for those born since 1 Jan 1969.


Aged 11 - 14 years, 2 doses given at least 5 months apart, even if 2nd dose given over 15 years  

Aged 15 - 27 years, standard schedule 0, 2, 6 months.  If shortened schedule necessary, minimum 4 weeks between dose 1 and 2 and 12 weeks between dose 2 and 3.


Born on or after 1 April 2016

Turned 11 years on or after 1 July 2017 (if non-immune)


65 years, 2 doses given 0 and 2-6 months apart.  Second dose funded at 66 years if first dose given at 65 years.

A one page version of the information above is available below, or you can print this as a factsheet using the print button on the top right of this page.


Download PDF

Last updated:
Dec 2022